Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model (Scientific Reports, (2025), 15, 1, (532), 10.1038/s41598-024-84380-6)

Shinri Sato; Yoko Ogawa; Kazuki Asai; Eisuke Shimizu; Shota Shimizu; Hiroko Taniguchi; Takahiro Okazaki; Shigeto Shimmura; Kazuno Negishi; Masatoshi Hirayama

doi:10.1038/s41598-025-88934-0

Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model (Scientific Reports, (2025), 15, 1, (532), 10.1038/s41598-024-84380-6)

Shinri Sato
, Yoko Ogawa
, Kazuki Asai
, Eisuke Shimizu
, Shota Shimizu
, Hiroko Taniguchi
, Takahiro Okazaki
, Shigeto Shimmura
, Kazuno Negishi
, Masatoshi Hirayama

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-024-84380-6, published online 02 January 2025 The Competing interests section in the original version of this Article was incorrect. “The authors declare no competing interests.” now reads: “S. Sato and E. S. received delgocitinib, 0.5% delgocitinib ointment and solvent vehicle ointments from JT, and the preparation method of delgocitinib eye drops was provided by ROHTO Pharmaceutical Co., Ltd. S. Shimizu, H. T., K. A., T.O., M. H., S. Shimmura, K. N., and Y. O. declare no financial or nonfinancial conflicts of interest associated with this manuscript.” The original Article has been corrected.

Original language	English
Article number	4404
Journal	Scientific reports
Volume	15
Issue number	1
DOIs	https://doi.org/10.1038/s41598-025-88934-0
Publication status	Published - 12-2025
Externally published	Yes

All Science Journal Classification (ASJC) codes

General

Access to Document

10.1038/s41598-025-88934-0

Fingerprint

Dive into the research topics of 'Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model (Scientific Reports, (2025), 15, 1, (532), 10.1038/s41598-024-84380-6)'. Together they form a unique fingerprint.

Cite this

Sato, S., Ogawa, Y., Asai, K., Shimizu, E., Shimizu, S., Taniguchi, H., Okazaki, T., Shimmura, S., Negishi, K., & Hirayama, M. (2025). Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model (Scientific Reports, (2025), 15, 1, (532), 10.1038/s41598-024-84380-6). Scientific reports, 15(1), Article 4404. https://doi.org/10.1038/s41598-025-88934-0

@article{482e61e4218e4b828053d25d374cf400,

title = "Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model (Scientific Reports, (2025), 15, 1, (532), 10.1038/s41598-024-84380-6)",

abstract = "Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-024-84380-6, published online 02 January 2025 The Competing interests section in the original version of this Article was incorrect. “The authors declare no competing interests.” now reads: “S. Sato and E. S. received delgocitinib, 0.5\% delgocitinib ointment and solvent vehicle ointments from JT, and the preparation method of delgocitinib eye drops was provided by ROHTO Pharmaceutical Co., Ltd. S. Shimizu, H. T., K. A., T.O., M. H., S. Shimmura, K. N., and Y. O. declare no financial or nonfinancial conflicts of interest associated with this manuscript.” The original Article has been corrected.",

author = "Shinri Sato and Yoko Ogawa and Kazuki Asai and Eisuke Shimizu and Shota Shimizu and Hiroko Taniguchi and Takahiro Okazaki and Shigeto Shimmura and Kazuno Negishi and Masatoshi Hirayama",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2025",

month = dec,

doi = "10.1038/s41598-025-88934-0",

language = "English",

volume = "15",

journal = "Scientific reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

number = "1",

}

Sato, S, Ogawa, Y, Asai, K, Shimizu, E, Shimizu, S, Taniguchi, H, Okazaki, T, Shimmura, S, Negishi, K & Hirayama, M 2025, 'Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model (Scientific Reports, (2025), 15, 1, (532), 10.1038/s41598-024-84380-6)', Scientific reports, vol. 15, no. 1, 4404. https://doi.org/10.1038/s41598-025-88934-0

Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model (Scientific Reports, (2025), 15, 1, (532), 10.1038/s41598-024-84380-6). / Sato, Shinri; Ogawa, Yoko; Asai, Kazuki et al.
In: Scientific reports, Vol. 15, No. 1, 4404, 12.2025.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Author Correction

T2 - Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model (Scientific Reports, (2025), 15, 1, (532), 10.1038/s41598-024-84380-6)

AU - Sato, Shinri

AU - Ogawa, Yoko

AU - Asai, Kazuki

AU - Shimizu, Eisuke

AU - Shimizu, Shota

AU - Taniguchi, Hiroko

AU - Okazaki, Takahiro

AU - Shimmura, Shigeto

AU - Negishi, Kazuno

AU - Hirayama, Masatoshi

PY - 2025/12

Y1 - 2025/12

N2 - Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-024-84380-6, published online 02 January 2025 The Competing interests section in the original version of this Article was incorrect. “The authors declare no competing interests.” now reads: “S. Sato and E. S. received delgocitinib, 0.5% delgocitinib ointment and solvent vehicle ointments from JT, and the preparation method of delgocitinib eye drops was provided by ROHTO Pharmaceutical Co., Ltd. S. Shimizu, H. T., K. A., T.O., M. H., S. Shimmura, K. N., and Y. O. declare no financial or nonfinancial conflicts of interest associated with this manuscript.” The original Article has been corrected.

AB - Correction to: Scientific Reportshttps://doi.org/10.1038/s41598-024-84380-6, published online 02 January 2025 The Competing interests section in the original version of this Article was incorrect. “The authors declare no competing interests.” now reads: “S. Sato and E. S. received delgocitinib, 0.5% delgocitinib ointment and solvent vehicle ointments from JT, and the preparation method of delgocitinib eye drops was provided by ROHTO Pharmaceutical Co., Ltd. S. Shimizu, H. T., K. A., T.O., M. H., S. Shimmura, K. N., and Y. O. declare no financial or nonfinancial conflicts of interest associated with this manuscript.” The original Article has been corrected.

UR - https://www.scopus.com/pages/publications/85218290838

UR - https://www.scopus.com/pages/publications/85218290838#tab=citedBy

U2 - 10.1038/s41598-025-88934-0

DO - 10.1038/s41598-025-88934-0

M3 - Comment/debate

C2 - 39910227

AN - SCOPUS:85218290838

SN - 2045-2322

VL - 15

JO - Scientific reports

JF - Scientific reports

IS - 1

M1 - 4404

ER -

Author Correction: Exploratory study on the efficacy of topical pan-JAK inhibitor in ocular and skin GVHD in a sclerodermatous GVHD mouse model (Scientific Reports, (2025), 15, 1, (532), 10.1038/s41598-024-84380-6)

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this